Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes.

Cancer medicine - 1 Mar 2021

Yan Xuefen, Wang Lu, Jiang Lingxu, Luo Yingwan, Lin Peipei, Yang Wenli, Ren Yanling, Ma Liya, Zhou Xinping, Mei Chen, Ye Li, Xu Gaixiang, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongyan

Abstract excerpt

PURPOSE: To explore the relevance of cytogenetic or molecular genetic abnormalities to clinical variables, including clinical and laboratory characteristics and prognosis in Chinese patients with myelodysplastic syndromes (MDS). METHODS: A total of 634 consecutive patients diagnosed with MDS at The First Affiliated Hospital, Zhejiang University School of Medicine from June 2008 to May 2018 were retrospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blast Crisis
Share to Bone Marrow

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 8

Share to Disease-Free Survival

Share to Karyotype

Share to Multivariate Analysis

Share to Myelodysplastic Syndromes

Share to Trisomy

Source

Open in PubMed Open full text

Identifiers

PMID: 33609081
DOI: 10.1002/cam4.3786
PMCID: PMC7940222

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance of cytogenetic and molecular genetic abnormalities in 634 Chinese patients with myelodysplastic syndromes.PMID 33609081Read ↗

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patientsSemantic proximity Read ↗

Cytogenetic features and prognosis analysis in Chinese patients with myelodysplastic syndrome: a multicenter study.Semantic proximity Read ↗

Cytogenetic features in myelodysplastic syndromesSemantic proximity Read ↗

Update on cytogenetic and molecular changes in myelodysplastic syndromes.Semantic proximity Read ↗

Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countriesSemantic proximity Read ↗

Implications of mutational spectrum in myelodysplastic syndromes based on targeted next-generation sequencingSemantic proximity Read ↗

Distinct mutation features and its clinical significance in myelodysplastic syndromes with normal karyotype.Semantic proximity Read ↗

Current diagnosis and treatment for myelodysplastc syndromes.Semantic proximity Read ↗

Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome.Semantic proximity Read ↗

Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.Semantic proximity Read ↗

[Clinical characteristics and prognosis of myelodysplastic neoplasms with chromosome 1 abnormalities].Semantic proximity Read ↗

Myelodysplastic syndromes: Updates on Genomic Landscape, Molecular Subtypes, & Targeted Therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.